Hi all,
just finished reading this article about FDA`s plans in the space for rare disease. In my opinion all points raised in this article, NEUREN already has a strategy in place, which is very much in line of what the FDA intends to do.
Happy reading
https://www.marketwatch.com/story/new-fda-program-could-boost-drug-development-for-rare-diseases-11644935201
Focus now on NNZ2591, page-58
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |